![Matthew Roden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Roden
Directeur Général chez
AKTIS ONCOLOGY, INC.
Fortune : 3 M $ au 30/06/2026
Profil
Le Dr Matt M. Roden est un directeur indépendant d'iTeos Therapeutics, Inc. et un partenaire exécutif de MPM Capital Inc, un président et directeur de Celgene Corp. et un président de Turmeric Acquisition Corp. Il siège au conseil d'administration d'iTeos Therapeutics, Inc, de Celgene Corp. et de BioNJ, Inc. Auparavant, le Dr Roden a été employé en tant que vice-président principal et chef de la stratégie d'entreprise chez Bristol Myers Squibb Co, directeur exécutif et analyste chez UBS Securities LLC, analyste chez Merrill Lynch, Pierce, Fenner & Smith, Inc. (anciennement), Head-Global Biotechnology Equity Research chez UBS Investment Bank (New York), Vice-président chez JPMorgan Securities, Inc. et analyste associé chez Credit Suisse Securities (USA) LLC (courtier), et associé chez Credit Suisse First Boston. Il a obtenu son diplôme de premier cycle à l'université George Mason, un diplôme d'études supérieures à l'université de Georgetown et un doctorat à l'Albert Einstein College of Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. 0,17 % | 09/01/2026 | 91 998 ( 0,17 % ) | 3 M $ | 30/06/2026 |
Dernières actualités sur Matthew Roden
Postes actifs de Matthew Roden
| Sociétés | Poste | Début |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Directeur Général | 01/09/2020 |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Directeur/Membre du Conseil | 01/01/2023 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/08/2020 |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Directeur/Membre du Conseil | 01/05/2024 |
Anciens postes connus de Matthew Roden
| Sociétés | Poste | Fin |
|---|---|---|
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Directeur/Membre du Conseil | 01/12/2024 |
| ITEOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/02/2023 |
| TURMERIC ACQUISITION CORP. | Président | 01/12/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2020 |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2016 |
Formation de Matthew Roden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Finance |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
UBS Investment Bank (New York)
 UBS Investment Bank (New York) Financial ConglomeratesFinance Provides financial services | Finance |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Renagade Therapeutics, Inc.
Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Health Technology |
